Given that we have already found that low TRIM38 depended on accumulated GLUT1 to drive tumor progression, we thus considered whether GLUT1 inhibitor could be effective to suppress tumour growth in TRIM38low BLCA. Here, TRIM38 is linked to bladder transitional cell carcinoma.